This article by Gina Kolata in the New York Times is well worth reading! It supports something that I have been predicting for a long time: that we will stop defining cancers by the organ they start in and instead by the molecular defects. Breast cancer and melanoma drugs for colon cancer! As Kolata explains:

“Scientists increasingly see cancer as a genetic disease defined not so much by where it starts — colon, liver, brain, breast — but by genetic aberrations that are its Achilles’ heel. And with a detailed understanding of which genetic changes make a cancer grow and thrive, they say they can figure out how best to mount an attack. They caution that most of the drugs needed to target the colon cancer mutations have yet to be developed, but they say they are building the road map that they hope will lead them to new treatments.”

You can read the full article here.

Share →

Leave a Reply

Your email address will not be published. Required fields are marked *